" /> Clinical Trial Expedited Safety Report Documentation - CISMeF





Preferred Label : Clinical Trial Expedited Safety Report Documentation;

NCIt related terms : Suspected Unexpected Serious Adverse Reaction (SUSAR); Exped Safe Rept; Investigational New Drug (IND) Safety Report; CIOMS Report; MedWatch; Expedited Safety Report;

Alternative definition : CareLex: Documentation that presents and summarizes the relevant findings and notification by the sponsor of unexpected serious adverse drug reactions and other safety information, which is submitted to regulatory authorities, investigators, Institutional Review Boards (IRBs) and/or Independent Ethics Committees (IECs). Reports may include but are not limited to CIOMS, MedWatch, Electronic Submission of AE Notification to FDA Reports, Analysis of Similar Events, cover letters, and/or country-specific reporting forms. [Adapted from TMF-RM]; CDISC: Documentation describing unexpected serious adverse events experienced by the subject and other safety information in the clinical trial, which are submitted to regulatory authorities and Institutional Review Boards or Independent Ethics Committees.;

Details


You can consult :


Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.